NCT04375449View on ClinicalTrials.gov

Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 4, 2020

Primary Completion Date

July 25, 2020

Study Completion Date

December 15, 2020

Conditions

Prediabetic State

Interventions

DIETARY_SUPPLEMENT

Pep2dia

what is the effect of Pep2dia on postprandial glycemia after a meal rich in carbohydrates (75g)

DIETARY_SUPPLEMENT

maltodextrin

Trial Locations (1)

Unknown

Biotesys, Esslingen am Neckar

All Listed Sponsors

collaborator

BioTeSys GmbH

OTHER

lead

Ingredia S.A.

INDUSTRY

NCT04375449 - Investigation of Milk Peptides (Pep2Dia®) on Postprandial Blood Glucose Profile in Prediabetic Subjects | Biotech Hunter | Biotech Hunter